Clinical Trials Directory

Trials / Unknown

UnknownNCT04798391

Effectiveness of Intratympanic Dexamethasone With Ligmocaine for Alleviation of Tinnitus

Effectiveness of Dexamethasone With Lignocaine for Alleviation of Tinnitus

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
264 (estimated)
Sponsor
Combined Military Hospital, Pakistan · Academic / Other
Sex
All
Age
19 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Objective: To determine the effectiveness of Intratympanic dexamethasone with lignocaine in control of idiopathic tinnitus. Methodology: 264 consenting patients with idiopathic unilateral tinnitus presenting at ENT Department were assessed for tinnitus severity using Modified Tinnitus Handicap Inventory and the scores recorded and subsequently administered intratympanically 2.0 ml (milliliter's) of dexamethasone and lignocaine (1.5 ml dexamethasone + 0.5 ml 1% lignocaine). The dose was repeated twice at weekly intervals. All patients were re assessed on Modified Tinnitus Handicap Inventory two weeks after third Intratympanic administration.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasoneSteroids and analgesics

Timeline

Start date
2021-03-01
Primary completion
2021-04-01
Completion
2021-05-01
First posted
2021-03-15
Last updated
2021-03-15

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT04798391. Inclusion in this directory is not an endorsement.

Effectiveness of Intratympanic Dexamethasone With Ligmocaine for Alleviation of Tinnitus (NCT04798391) · Clinical Trials Directory